TAF1L (BD2) Inhibitor Screening Assay Kit

Catalog #
32602
$1,025 *
Size: 384 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The TAF1L (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of TAF1L binding to its substrate. The key to the assay kit is specific binding of the TAF1L bromodomain 2 (a.a. 1517-1649) to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing TAF1L and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

Synonyms
TAF1 RNA polymerase II, TAT box binding protein (TBP)-associated factor, TAF1L, activity assay kit
Product Info
Storage and Usage
Citations
Assay Kit Format
AlphaLISA®
Supplied As
Kit comes in a convenient AlphaLISA® format with enough biotinylated histone peptide substrate, assay buffer, detection buffer, and purified GST-tagged TAF1L bromodomain to perform a total of 384 enzyme reactions.
Materials Required But Not Supplied
MATERIALS OR INSTRUMENTS REQUIRED BUT NOT SUPPLIED:
Glutathione AlphaLISA® Acceptor Beads, 5 mg/ml (PerkinElmer #AL109C)
AlphaScreen® Streptavidin-conjugated donor beads, 5 mg/ml (PerkinElmer #6760002)
Optiplate-384 (PerkinElmer #6007290)
AlphaScreen® microplate reader
Adjustable micropipettor and sterile tips
Format

COMPONENTS:

UniProt #
Q8IZX4
References
Wang, P.J., and Page, D.C., Human Molecular Genetics; 2002, 11:2341-2346.